Denali Therapeutics 401(K) Plan — Form 5500 plan (Denali Therapeutics Inc.)
Plain-English plan summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, Denali Therapeutics 401(K) Plan is a benefit plan reported by Denali Therapeutics Inc. under EIN 46-3872213 and plan number 001. The latest loaded filing year is 2023. The filing reports 424 participants and $49,662,877 in end-of-year plan assets, where available in the loaded dataset.
Key reported metrics
- Plan sponsor
- Denali Therapeutics Inc.
- EIN
- 46-3872213
- Plan number
- 001
- Plan type
- 2
- Location
- South San Francisco, CA
- Latest filing year
- 2023
- Participants
- 424
- End-of-year plan assets
- $49,662,877
Form 5500 filing history
| Filing year | Participants | Schedules | Filing |
|---|---|---|---|
| 2023 | 424 | H | 20240930104012NAL0010005248001 |
Reported financial statement (2023 · Schedule H)
Net assets
- Total assets (EOY)
- $49,662,877
- Total liabilities (EOY)
- $0
- Net assets (EOY)
- $49,662,877
- Net assets (BOY)
- $32,052,603
Income & contributions
- Employer contributions
- $3,213,315
- Participant contributions
- $6,797,370
- Total contributions
- $12,514,796
- Total income / additions
- $19,780,813
Expenses & distributions
- Benefits paid
- $2,168,951
- Administrative expenses
- $1,079
- Total expenses
- $2,170,539
- Net increase / (decrease)
- $17,610,274
Service provider compensation (Schedule C)
No Schedule C service provider compensation is loaded for this plan yet.